XML 66 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Options
9 Months Ended
Sep. 30, 2014
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
7.
Stock Options
 
The Company adopted, with stockholder approval, amendments to the Innodata Inc. 2013 Stock Plan. The maximum number of shares of common stock that may be delivered, purchased or used for reference purposes (with respect to stock appreciation rights or stock units) with respect to awards granted under the Innodata Inc. 2013 Stock Plan, as amended and restated (the “2013 Plan”) is 2,138,655 shares of common stock of Innodata (“Stock”), plus (i) 41,096 shares of Stock that were available for issuance under the Innodata Isogen, Inc. 2009 Stock Plan, as amended and restated (the “Prior Plan”) as of June 4, 2013, plus (ii) any shares subject to an award or portion of any award under the Prior Plan that were outstanding as of June 4, 2013 that expire or terminate unexercised, become unexercisable or are forfeited or otherwise terminated, surrendered or canceled as to any shares without the delivery of shares of stock or other consideration. Shares of stock subject to options or stock appreciation rights granted under the 2013 Plan count against the share reserve as one share for every one share subject to such option or stock appreciation right and shares subject to any other type of award granted under the 2013 Plan count against the share reserve as two shares for every one share subject to such award. If any award, or portion of an award, under the 2013 Plan or Prior Plan expires or terminates unexercised, becomes unexercisable or is forfeited or otherwise terminated, surrendered or canceled as to any shares without the delivery of shares of Stock or other consideration, the shares subject to such award will thereafter be available for further awards under the 2013 Plan as provided in the next sentence. Shares of Stock that again become available for awards pursuant to the expiration, termination, forfeiture or cancellation of any award (other than an option or stock appreciation right) granted under the 2013 Plan, or of any award (other than an option or stock appreciation right) granted after March 31, 2011 under the Prior Plan, will be added back as two shares for every one share subject to such award or Prior Plan award. All other awards under the 2013 Plan and all other awards under the Prior Plan will be added back as one share for every one share subject to such award or Prior Plan award. The number of shares used for reference purposes in connection with these awards will be considered "delivered" for purposes of computing the maximum number of shares that may be delivered under the 2013 Plan.
  
A summary of option activity under the Company’s stock option plans as of September 30, 2014, and changes during the period then ended, is presented below:
 
 
 
 
 
Weighted-
 
 
 
 
 
 
 
Average
 
 
 
 
 
 
Weighted-
Remaining
 
 
 
 
Number of
 
Average
Contractual
 
Aggregate
 
 
Options
 
Exercise Price
Term (years)
 
Intrinsic Value
 
Outstanding at January 1, 2014
 
 
3,048,069
 
$
2.99
 
 
 
 
 
 
 
Granted
 
 
1,292,000
 
 
2.79
 
 
 
 
 
 
 
Exercised
 
 
(434,200)
 
 
1.73
 
 
 
 
 
 
 
Forfeited/Expired
 
 
(264,012)
 
 
3.24
 
 
 
 
 
 
 
Outstanding at September 30, 2014
 
 
3,641,857
 
$
3.05
 
 
5.17
 
$
818,961
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at September 30, 2014
 
 
1,336,732
 
$
3.04
 
 
3.87
 
$
422,436
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vested and Expected to Vest at September 30, 2014
 
 
3,641,857
 
$
3.04
 
 
5.17
 
$
818,961
 
 
The fair value of stock options is estimated on the date of grant using the Black-Scholes option pricing model. The weighted average fair values of the options granted and weighted average assumptions are as follows:
 
 
 
Nine Months Ended
 
 
 
September 30,
 
 
 
2014
 
 
 
2013
 
Weighted average fair value of options granted
 
$
1.35
 
 
 
$
1.89
 
 
 
 
 
 
 
 
 
 
 
Risk-free interest rate
 
 
1.53% -1.68
%
 
 
 
0.76
%
Expected life (years)
 
 
5
 
 
 
 
5-7
 
Expected volatility factor
 
 
54.96
%
 
 
 
67.37
%
Expected dividends
 
 
-
 
 
 
 
-
 
 
A summary of restricted shares under the Company’s stock plans as of September 30, 2014, and changes during the period then ended, are presented below:
 
 
 
 
Weighted-
 
 
 
 
Average Grant
 
 
Number of Shares
 
Date Fair Value
 
Unvested at January 1, 2014
 
 
25,000
 
$
3.31
 
Granted
 
 
-
 
 
-
 
Vested
 
 
(17,500)
 
 
3.62
 
Forfeited/Expired
 
 
-
 
 
-
 
Unvested at September 30, 2014
 
 
7,500
 
$
2.59
 
 
The total compensation cost related to non-vested stock awards not yet recognized as of September 30, 2014 totaled approximately $2.3 million. The weighted-average period over which these costs will be recognized is twenty-five months.
  
The stock-based compensation expense related to the Company’s various stock awards was allocated as follows (in thousands):
 
 
 
Three months ended
 
Nine months ended
 
 
 
September 30,
 
September 30,
 
 
 
2014
 
2013
 
2014
 
2013
 
 
 
 
 
 
 
 
 
 
 
Direct operating costs
 
$
107
 
$
76
 
$
283
 
$
205
 
Selling and administrative expenses
 
 
195
 
 
160
 
 
563
 
 
520
 
Total stock-based compensation
 
$
302
 
$
236
 
$
846
 
$
725
 
 
In March 2014 the Company’s Chairman and CEO (the “CEO”) exercised 154,000 stock options at a total exercise price of $0.4 million. The CEO paid the exercise price by surrendering to the Company 137,065 of the shares of common stock he would have otherwise received on the option exercise. In addition, the CEO surrendered 7,866 shares to the Company in consideration of the payment by the Company on his behalf of $22,891 of the Company’s minimum withholding tax requirement payable in respect of the option exercise. Because the payment value attributable to the surrendered shares upon settlement does not exceed the fair value of the option, no compensation cost was recognized at the date of settlement. In connection with this transaction, the Company issued a net total of 9,069 shares of common stock to the CEO.